Kroger says cyclosporiasis outbreak cost over $100M in lost sales
Kroger reported a $641M profit on $24.6B sales, missing analyst estimates. The company attributed a $100M+ sales loss to a summer cyclosporiasis outbreak, which drove shoppers away from produce. Kroger also lowered its 2026 sales forecast to 0.2%-0.8% growth, down from 1%-2%.
How this was made

The 30-second read
Why it matters
The guidance cut suggests lower future cash flows, prompting a likely downgrade by analysts and a sell‑off in the stock.
Market read
Kroger's earnings miss and guidance cut are material for investors in consumer staples, potentially influencing sector sentiment.
What to watch
Kroger's diversified banner portfolio and strong e‑commerce platform may mitigate long‑term revenue damage.
Background
Kroger reported Q2 results, highlighting a $100M+ sales hit from a food‑borne illness outbreak and a major downward revision of its 2026 sales outlook.
Ticker impact
Kroger disclosed a $100M+ sales loss from a cyclosporiasis outbreak and cut its 2026 sales forecast by more than half.
Downward pressure on KR stock in the near term as investors reassess revenue outlook.
Guidance cuts of this magnitude for a large-cap retailer are rare and directly affect valuation multiples.
Market effects
Potentially pressures other grocery and consumer staples stocks as analysts may lower sector forecasts.
U.S. retail sector could see modest pullback in the short term.
Limited to U.S. markets; no direct global macro effect.
Counterpoint
If the outbreak is contained quickly, the sales impact may be temporary and the stock could rebound.
Key entities
- CompanyKroger Co.
Largest U.S. supermarket chain, ticker KR.
- ExecutiveGreg Foran
CEO of Kroger, provided the earnings commentary.





